The cyclooxygenase system participates in functional mdr1b overexpression in primary rat hepatocyte cultures

Smit, 1993, Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease, Cell, 75, 451, 10.1016/0092-8674(93)90380-9 Gottesman, 1993, Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu Rev Biochem, 62, 385, 10.1146/annurev.bi.62.070193.002125 Johnstone, 2000, Multiple physiological functions for multidrug transporter P-glycoprotein?, Trends Biochem Sci, 25, 1, 10.1016/S0968-0004(99)01493-0 Silverman, 1997, Hepatic canalicular membrane 4: expression of the multidrug resistance genes in the liver, FASEB J, 11, 308, 10.1096/fasebj.11.5.9141496 Bradley, 1992, P-glycoprotein expression during tumor progression in the rat liver, Cancer Res, 52, 5154 Huang, 1992, Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma, J Natl Cancer Inst, 84, 262, 10.1093/jnci/84.4.262 Schrenk, 1993, Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates, Hepatology, 17, 854, 10.1002/hep.1840170516 Vos, 1998, Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver, Hepatology, 28, 1637, 10.1002/hep.510280625 Marino, 1990, Regulation of the multidrug resistance gene in regenerating rat liver, Cell Growth Differ, 1, 57 Koga, 1999, Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation, Hepatology, 29, 688, 10.1002/hep.510290355 Shiota, 1999, Cyclooxygenase-2 expression in hepatocellular carcinoma, Hepatogastroenterology, 46, 407 Nagasue, 1995, Overexpression of P-glycoprotein in adenomatous hyperplasia of human liver with cirrhosis, J Hepatol, 22, 197, 10.1016/0168-8278(95)80429-3 Takanishi, 1997, Inverse relationship between P-glycoprotein expression and its proliferative activity in hepatocellular carcinoma, Oncology, 54, 231, 10.1159/000227694 Fosslien, 2000, Molecular pathology of cyclooxygenase-2 in neoplasia, Ann Clin Lab Sci, 30, 3 Marnett, 1999, Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition, J Biol Chem, 274, 22903, 10.1074/jbc.274.33.22903 Skouteris, 1988, Regulation of the proliferation of primary rat hepatocytes by eicosanoids, J Cell Physiol, 135, 516, 10.1002/jcp.1041350321 Besse, 1991, Stimulation of liver regeneration by prostacyclin, Transplant Proc, 23, 542 Skouteris, 1992, Transforming growth factor-alpha-induced DNA synthesis and c-myc expression in primary rat hepatocyte cultures is modulated by indomethacin, Biochem J, 281, 729, 10.1042/bj2810729 Tsujii, 1993, Prostaglandin E2 and rat liver regeneration, Gastroenterology, 105, 495, 10.1016/0016-5085(93)90725-R Hirsch-Ernst, 1995, Modulation of P-glycoprotein and mdr1b mRNA expression by growth factors in primary rat hepatocyte culture, Biochem Biophys Res Commun, 215, 179, 10.1006/bbrc.1995.2450 Lee, 1995, Overexpression of the class II P-glycoprotein gene in primary rat hepatocyte culture: evidence for increased mRNA stability, Cell Growth Differ, 6, 347 Hirsch-Ernst, 1998, Induction of mdr1b mRNA and P-glycoprotein expression by tumor necrosis factor alpha in primary rat hepatocyte cultures, J Cell Physiol, 176, 506, 10.1002/(SICI)1097-4652(199809)176:3<506::AID-JCP7>3.0.CO;2-S Ziemann, 1999, Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures, Carcinogenesis, 20, 407, 10.1093/carcin/20.3.407 Di Popolo, 2000, IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells, Oncogene, 19, 5517, 10.1038/sj.onc.1203952 Adderley, 1999, Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases ½-mediated induction of cyclooxygenase-2, J Biol Chem, 274, 5038, 10.1074/jbc.274.8.5038 Schuetz, 1995, Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids, Cell Growth Differ, 6, 1321 Hoffmann, 1989, Proliferation of fetal rat hepatocytes in response to growth factors and hormones in primary culture, J Cell Physiol, 139, 654, 10.1002/jcp.1041390328 Schäfer, 1996, Effect of prostaglandin E2 on eicosanoid release by human bronchial biopsy specimens from normal and inflamed mucosa, Thorax, 51, 919, 10.1136/thx.51.9.919 Draper, 1997, Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein, Br J Cancer, 75, 810, 10.1038/bjc.1997.145 Futaki, 1994, NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2 activity in vitro, Prostaglandins, 47, 55, 10.1016/0090-6980(94)90074-4 Sato, 1997, Enhancement of prostaglandin E2 production by epidermal growth factor requires the coordinate activation of cytosolic phospholipase A2 and cyclooxygenase 2 in human squamous carcinoma A431 cells, Prostaglandins, 53, 355, 10.1016/S0090-6980(97)00036-1 Perkins, 1997, Rapid and transient induction of cyclooxygenase 2 by epidermal growth factor in human amnion-derived WISH cells, Biochem J, 321, 677, 10.1042/bj3210677 Hirsch-Ernst, 2000, Physiological oxygen tensions modulate expression of the mdr1b multidrug-resistance gene in primary rat hepatocyte cultures, Biochem J, 350, 443, 10.1042/bj3500443 Uchiumi, 1993, Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation, Cell Growth Differ, 4, 147 Boie, 1997, Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes, Eur J Pharmacol, 340, 227, 10.1016/S0014-2999(97)01383-6 Negishi, 1993, Prostanoid receptors and their biological actions, Prog Lipid Res, 32, 417, 10.1016/0163-7827(93)90017-Q Wartenberg, 2000, Redox regulation of P-glycoprotein-mediated multidrug resistance in multicellular prostate tumor spheroids, Int J Cancer, 85, 267, 10.1002/(SICI)1097-0215(20000115)85:2<267::AID-IJC19>3.0.CO;2-H Ros, 2001, Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-κB signaling, Hepatology, 33, 1425, 10.1053/jhep.2001.24667 Thevenod, 2000, Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis, J Biol Chem, 275, 1887, 10.1074/jbc.275.3.1887 Deng, 2001, 2-Acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-kappa B pathway, J Biol Chem, 276, 413, 10.1074/jbc.M004551200 Zhou, 1998, Wild-type p53-mediated induction of rat mdr1b expression by the anticancer drug daunorubicin, J Biol Chem, 273, 15387, 10.1074/jbc.273.25.15387 Silverman, 1995, Characterization of the basal and carcinogen regulatory elements of the rat mdr1b promoter, Mol Carcinog, 13, 50, 10.1002/mc.2940130109 Thottassery, 1999, Sp1 and Egr-1 have opposing effects on the regulation of the rat Pgp2/mdr1b gene, J Biol Chem, 274, 3199, 10.1074/jbc.274.5.3199 Meyer-Kirchrath, 1998, Analysis of a porcine EP3-receptor: cloning, expression and signal transduction, Naunyn Schmiedebergs Arch Pharmacol, 358, 160, 10.1007/PL00005238 Tegeder, 2001, Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen, FASEB J, 15, 2, 10.1096/fasebj.15.1.2 Niederberger, 2001, Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB, FASEB J, 15, 1622, 10.1096/fj.00-0716fje Callejas, 1999, Inhibition of prostaglandin synthesis up-regulates cyclooxygenase-2 induced by lipopolysaccharide and peroxisomal proliferators, J Pharmacol Exp Ther, 288, 1235 Simmons, 1999, Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs, Proc Natl Acad Sci U S A, 96, 3275, 10.1073/pnas.96.6.3275 Vogel, 2000, Regulation of prostaglandin endoperoxide H synthase-2 induction by dioxin in rat hepatocytes: possible c-Src-mediated pathway, Carcinogenesis, 21, 2267, 10.1093/carcin/21.12.2267 Callejas, 2000, Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins, Gastroenterology, 119, 493, 10.1053/gast.2000.9374